Calithera Biosciences Receives $40,000,000 Series A Round

  • Feed Type
  • Date
  • Company Name
    Calithera Biosciences
  • Mailing Address
    Undisclosed San Francisco, CA 94100
  • Company Description
    The company is developing a new class of anticancer therapeutics based on activation of caspases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Specific proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    U.S. Venture Partners
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    Delphi Ventures
  • Venture Investor

Trending on Xconomy